×
About 438 results

ALLMedicine™ Schizophreniform Disorder Center

Research & Reviews  213 results

A commentary revisiting the viral hypothesis of schizophrenia: Onset of a schizophrenif...
https://doi.org/10.1016/j.psychres.2020.113573
Psychiatry Research; DeLisi LE

Nov 23rd, 2020 - The viral hypothesis for schizophrenia has persisted for decades, initially supported by observed increases in psychoses subsequent to the influenza pandemic of the early twentieth century, and then later by evidence of elevated viral antibody tit...

A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia...
https://clinicaltrials.gov/ct2/show/NCT02431702

Nov 19th, 2019 - A Prospective, matched-control, Randomized (assignment of study drug by chance), open-label, flexible-dose, study in participants with recent-onset schizophrenia or schizophreniform disorder to compare disease progression and disease modification ...

Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking ...
https://doi.org/10.1097/FTD.0000000000000695
Therapeutic Drug Monitoring; Miroshnichenko II, Pozhidaev IV et. al.

Aug 19th, 2019 - The relationship between a daily dose of olanzapine, its serum concentration, and the genotype of young nonsmoking men treated for schizophrenia or schizophreniform disorder was investigated in day-to-day clinical practice. Pharmacogenetics was al...

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831
https://clinicaltrials.gov/ct2/show/NCT03201757

Aug 4th, 2019 - This study will evaluate the long-term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar I disorder

Informed consent and ethical reporting of research in clinical trials involving partici...
https://doi.org/10.1016/j.cct.2019.06.009
Contemporary Clinical Trials; Weissinger GM, Ulrich CM

Jun 27th, 2019 - Informed consent is critical for protecting vulnerable individuals interested in research participation, like those with psychotic disorders (e.g. schizophrenia, schizoaffective disorder, schizophreniform disorder, etc.). Individuals with psychoti...

see more →

Clinicaltrials.gov  219 results

A commentary revisiting the viral hypothesis of schizophrenia: Onset of a schizophrenif...
https://doi.org/10.1016/j.psychres.2020.113573
Psychiatry Research; DeLisi LE

Nov 23rd, 2020 - The viral hypothesis for schizophrenia has persisted for decades, initially supported by observed increases in psychoses subsequent to the influenza pandemic of the early twentieth century, and then later by evidence of elevated viral antibody tit...

A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia...
https://clinicaltrials.gov/ct2/show/NCT02431702

Nov 19th, 2019 - A Prospective, matched-control, Randomized (assignment of study drug by chance), open-label, flexible-dose, study in participants with recent-onset schizophrenia or schizophreniform disorder to compare disease progression and disease modification ...

Therapeutic Drug Monitoring of Olanzapine and Cytochrome P450 Genotyping in Nonsmoking ...
https://doi.org/10.1097/FTD.0000000000000695
Therapeutic Drug Monitoring; Miroshnichenko II, Pozhidaev IV et. al.

Aug 19th, 2019 - The relationship between a daily dose of olanzapine, its serum concentration, and the genotype of young nonsmoking men treated for schizophrenia or schizophreniform disorder was investigated in day-to-day clinical practice. Pharmacogenetics was al...

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831
https://clinicaltrials.gov/ct2/show/NCT03201757

Aug 4th, 2019 - This study will evaluate the long-term safety, tolerability, and durability of treatment effect of ALKS 3831 in subjects with schizophrenia, schizophreniform disorder, or bipolar I disorder

Informed consent and ethical reporting of research in clinical trials involving partici...
https://doi.org/10.1016/j.cct.2019.06.009
Contemporary Clinical Trials; Weissinger GM, Ulrich CM

Jun 27th, 2019 - Informed consent is critical for protecting vulnerable individuals interested in research participation, like those with psychotic disorders (e.g. schizophrenia, schizoaffective disorder, schizophreniform disorder, etc.). Individuals with psychoti...

see more →

News  5 results

She’s Not My Mother: A 24-Year-Old Man With Capgras Delusion
https://www.mdedge.com/fedprac/article/153379/mental-health/shes-not-my-mother-24-year-old-man-capgras-delusion/page/0/1

Dec 22nd, 2017 - Discussion The Capgras delusion can present in several different contexts. A psychiatric differential diagnosis includes disorders in the schizophrenia spectrum (brief psychotic disorder, schizophreniform disorder, and schizophrenia), schizoaffect.

Clozapine for First-Episode Schizophrenia: 9 Years Later
https://www.medscape.com/viewarticle/739828

Apr 3rd, 2011 - Clozapine v. Chlorpromazine in Treatment-Naive, First-Episode Schizophrenia: 9-Year Outcomes of a Randomised Clinical Trial Girgis RR, Phillips MR, Li X, et al Br J Psychiatry. 2011 Feb 3. [Epub ahead of print] Study Summary The study authors comp...

FDA Regulation of ECT Devices in Transition
https://www.mdedge.com/internalmedicine/article/20514/mental-health/fda-regulation-ect-devices-transition/page/0/1

Feb 9th, 2011 - Several of the psychiatrists on the panel who supported a switch to class II for ECT when used to treat the bipolar indication cited the need for alternative treatments and the few treatment options available for severely ill treatment resistant p.

Schizophrenia: An Inflammatory Disease That Can Be Treated With Aspirin?
https://www.medscape.com/viewarticle/723221

Jun 13th, 2010 - Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial Laan W, Grobbee DE, Selten JP, et al. J Clin Psychiatry. 2010;71:520-527 Summary This randomized, doub...

Schizoaffective disorder: Which symptoms should be treated first?
https://www.mdedge.com/psychiatry/article/66151/schizophrenia-other-psychotic-disorders/schizoaffective-disorder-which/page/0/2

Patient management When faced with a patient who meets criteria for schizoaffective disorder, I believe practical considerations can guide treatment. The label “schizoaffective disorder” reminds us to consider treatment of these patients broadly (.

see more →

Patient Education  1 results see all →